Moses Jennifer K.

Moses Jennifer K. is listed in filings as Director at Viridian Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2025, including 2 public disclosures. Recent filings connect the profile to Viridian Therapeutics, Inc. (VRDN). The current snapshot covers public activity from Jun 28, 2024 to Jul 2, 2025. Reported amounts are shown as $303.9K to $258.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.